Synonym: (4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
CAS Number: 154598-52-4
Empirical Formula (Hill Notation): C14H9ClF3NO2
Molecular Weight: 315.67
Linear Formula: C14H9ClF3NO2
Product Type: Chemical
| concentration |
10 mg/mL in DMSO |
| form |
DMSO solution |
| InChI |
1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1 |
| InChI key |
XPOQHMRABVBWPR-ZDUSSCGKSA-N |
| Quality Level |
200  |
| shipped in |
dry ice |
| SMILES string |
FC(F)(F)[C@]2(OC(=O)Nc3c2cc(cc3)Cl)C#CC1CC1 |
| storage temp. |
−20°C |
| Biochem/physiol Actions: |
Efavirenz is a nonnucleoside reverse transcriptase inhibitor (NNRTI). |
| Biochem/physiol Actions: |
Efavirenz is a nonnucleoside reverse transcriptase inhibitor (NNRTI). Efavirenz is an anti-HIV drug, commonly used in combination therapy for AIDs treatment. Efavirenz is part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1. |
| Biochem/physiol Actions: |
The plasma levels of this drug can determine the failure of treatment and CNS (central nervous system) side-effects in patients infected with HIV (human immunodeficiency virus). |
| Storage Temp. |
−20°C |
| UNSPSC |
12352200 |